AGR2 diagnostic value in nasopharyngeal carcinoma prognosis
ConclusionSerum AGR2 can be used as a serum marker for clinical prognosis of nasopharyngeal carcinoma. However, serum AGR2 levels could not provide advantages in clinical practice for the differential diagnosis of cancer.
Source: Clinica Chimica Acta - Category: Laboratory Medicine Source Type: research
More News: Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Nasopharyngeal Cancer | Study